Quantcast
Last updated on April 21, 2014 at 12:45 EDT

Latest Pre-exposure prophylaxis Stories

2014-03-06 16:27:36

SAN FRANCISCO, March 6, 2014 /PRNewswire-USNewswire/ -- San Francisco AIDS Foundation has appointed Robert Grant, MD, MPH, as chief medical officer, with special focus on advancing the foundation's work to combat HIV/AIDS by creating the first-ever dedicated home for health and wellness for gay and bisexual men in San Francisco. Dr. Grant brings more than 26 years of experience in HIV/AIDS clinical care and research. In 2012, he was named one of TIME magazine's 100 most influential...

2013-12-09 08:30:18

CAPE TOWN, South Africa, Dec. 9, 2013 /PRNewswire-USNewswire/ -- In a report released today, AVAC calls on funders and researchers to capitalize on lessons learned from a range of recent HIV prevention trials with better problem solving, more critical thinking and coordinated action around large-scale human trials, faster roll out of proven options and ongoing research for new advances that women and men will want to use. This year's AVAC Report, entitled Research and Reality, pays...

2013-12-02 23:27:21

PEP Angels announced today that it will begin delivering HIV exams to metro-area homes twenty-four hours a day - seven days a week - according to Matt Rice, who founded PEP Angels in March of 2013. Kansas City, MO (PRWEB) December 02, 2013 PEP Angels announced today that it will begin delivering HIV exams to metro-area homes twenty-four hours a day - seven days a week - according to Matt Rice, who founded PEP Angels in March of 2013. Many reports state that nearly 1 in 5 people are...

2013-06-30 04:20:10

New global report released at IAS 2013 highlights funding trends, opportunities and challenges for HIV prevention R&D KUALA LUMPUR, Malaysia, June 30, 2013 /PRNewswire-USNewswire/ -- Recent breakthroughs in HIV prevention research have confirmed the promise of new options to help end the AIDS epidemic and highlight the urgent need for ongoing research to develop additional prevention options and support rapid rollout of proven ones. However, continued progress requires a broader base...

Tenofovir Helps Prevent Contraction Of HIV
2013-06-13 13:20:00

Brett Smith for redOrbit.com - Your Universe Online New research from the Centers for Disease Control and Prevention suggests that a daily pill can prevent the contraction of HIV for intravenous drug users. The four-year study, which was published in The Lancet, boosts the argument of those advocating a preventative strategy called “¯pre-exposure prophylaxis, or PrEP. "This is a significant step forward for HIV prevention," Jonathan Mermin, a CDC spokesman who was not...

2013-06-12 16:26:31

AVAC Calls for Accelerated Action to Get PrEP to Those Who Can Benefit From It NEW YORK, June 12, 2013 /PRNewswire-USNewswire/ -- Results from the Bangkok Tenofovir Study published online today in The Lancet provide additional evidence that daily oral tenofovir-based pre-exposure prophylaxis (PrEP) reduces HIV infection risk when taken consistently. The results from the study--the first conducted among people who inject drugs--are consistent with previous studies among men and women...

2013-03-04 12:28:38

VOICE Results Underscore Need for Clear, US-Based PrEP Implementation Agenda ATLANTA, March 4, 2013 /PRNewswire-USNewswire/ -- The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women's health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at...

2013-03-04 12:28:19

PrEP Strategies Remain Valuable Prevention Tool, says AVAC NEW YORK, March 4, 2013 /PRNewswire-USNewswire/ -- Results from a large-scale HIV prevention trial among African women known as VOICE (Vaginal and Oral Interventions to Control the Epidemic) provide an urgent reminder that products must meet the needs of the people using them. While disappointing, the results lend new urgency and direction to the search for additional safe and effective HIV prevention options for women, AVAC said...

2012-09-28 10:23:06

RESEARCH TRIANGLE PARK, N.C., Sept. 28, 2012 /PRNewswire/ -- Grifols, a global healthcare company that produces medicines derived from human plasma, announced today it has a robust inventory of HyperRAB® S/D (rabies immune globulin [human]) to overcome U.S. supply constraints caused by an increase in rabies exposures during 2012. HyperRAB® S/D provides immediate immune protection to patients who are exposed to rabies but have not yet been vaccinated against the deadly virus. (Logo:...

2012-09-17 02:25:26

SAN FRANCISCO, Sept. 17, 2012 /PRNewswire-USNewswire/-- Getting reliable, easy-to-understand information about a groundbreaking new HIV prevention strategy just got easier. The strategy, known as pre-exposure prophylaxis (PrEP), is the focus of a new website, PrEPfacts.org, developed by San Francisco AIDS Foundation in collaboration with the San Francisco Department of Public Health (SFDPH), National Institute of Allergy and Infectious Diseases, and other community partners....